<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73982</article-id><article-id pub-id-type="doi">10.7554/eLife.73982</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-193059"><name><surname>Kirkemo</surname><given-names>Lisa L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1686-6987</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-88420"><name><surname>Elledge</surname><given-names>Susanna K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254425"><name><surname>Yang</surname><given-names>Jiuling</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254423"><name><surname>Byrnes</surname><given-names>James R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0297-1209</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254424"><name><surname>Glasgow</surname><given-names>Jeff E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-112378"><name><surname>Blelloch</surname><given-names>Robert</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1975-0798</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6510"><name><surname>Wells</surname><given-names>James A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8267-5519</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmaceutical Chemistry</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Urology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1032"><name><surname>Schekman</surname><given-names>Randy</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jim.wells@ucsf.edu</email> (JW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73982</elocation-id><history><date date-type="received"><day>16</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>07</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Kirkemo et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Kirkemo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73982-v1.pdf"/><abstract><p>Characterization of cell surface proteome differences between cancer and healthy cells is a valuable approach for the identification of novel diagnostic and therapeutic targets. However, selective sampling of surface proteins for proteomics requires large samples (&gt;10e6 cells) and long labeling times. These limitations preclude analysis of material-limited biological samples or the capture of rapid surface proteomic changes. Here, we present two labeling approaches to tether exogenous peroxidases (APEX2 and HRP) directly to cells, enabling rapid, small-scale cell surface biotinylation without the need to engineer cells. We used a novel lipidated DNA-tethered APEX2 (DNA-APEX2), which upon addition to cells promoted cell agnostic membrane-proximal labeling. Alternatively, we employed horseradish peroxidase (HRP) fused to the glycan binding domain of wheat germ agglutinin (WGA-HRP). This approach yielded a rapid and commercially inexpensive means to directly label cells containing common N-Acetylglucosamine (GlcNAc) and sialic acid glycans on their surface. The facile WGA-HRP method permitted high surface coverage of cellular samples and enabled the first comparative surface proteome characterization of cells and cell-derived small extracellular vesicles (EV), leading to the robust quantification of 953 cell and EV surface annotated proteins. We identified a newly-recognized subset of EV-enriched markers, as well as proteins that are uniquely upregulated on Myc oncogene-transformed prostate cancer EVs. These two cell-tethered enzyme surface biotinylation approaches are highly advantageous for rapidly and directly labeling surface proteins across a range of material-limited sample types.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>1F31CA247527</award-id><principal-award-recipient><name><surname>Kirkemo</surname><given-names>Lisa L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>1650113</award-id><principal-award-recipient><name><surname>Elledge</surname><given-names>Susanna K</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>U01CA244452</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Jiuling</given-names></name><name><surname>Blelloch</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM122451</award-id><principal-award-recipient><name><surname>Wells</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA248323</award-id><principal-award-recipient><name><surname>Wells</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Chan Zuckerberg Biohub Investigator Program</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Wells</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Harry and Dianna Hind Professorship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Wells</surname><given-names>James A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data has been deposited alongside the manuscript as supporting source data files. Raw western blot images are made available as a source file titled &quot;Raw_WesternBlot&quot;. All data from mass spectrometry experiment is provided as source data within the manuscript. &quot;Figure 3-source data 2&quot; details the quantification results from the RWPE-1 +/- Myc cell comparison experiments. &quot;Figure 4-source data 2&quot; details the quantification results from the RWPE-1 +/- Myc EV comparison experiments. &quot;Figure 4-source data 3&quot; details the quantification results from the RWPE-1 +/- Myc whole EV experiments. &quot;Figure 5-source data 2&quot; details the quantification results from PEAKS and Perseus for the RWPE-1 +/- Myc EV and cell comparison experiments.&quot;PaTu8902_WGAvsAPEX2_DatabaseSearch&quot; and &quot;KP4_APEX_HRP_Comparison_DatabaseSearch&quot; documents detail results from APEX2 and HRP method comparisons across two different PDAC cell lines.&quot;RWPE_Method_Comparison_DatabaseSearch&quot; outlines the results from the NHS-biotin, biocytin hydrazide, and WGA-HRP comparison experiments performed on RWPE EV and Myc transduced cells.The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD028523.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Lisa L Kirkemo</collab><collab>Susanna K Elledge</collab><collab>Jiuling Yang</collab><collab>James Byrnes</collab><collab>Jeff Glasgow</collab><collab>Robert Blelloch</collab><collab>James A Wells</collab></person-group><year iso-8601-date="2021">2021</year><source>Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD028523">https://www.ebi.ac.uk/pride/archive/projects/PXD028523</ext-link><comment>PRIDE, PXD028523</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-73982-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>